Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients

PURPOSE: Accumulating studies have investigated the prognostic and clinical significance of programmed death ligand-1 (PD-L1) expression in patients with hepatocellular carcinoma (HCC); however, the results were conflicting and inconclusive. We conducted a meta-analysis to combine controversial data...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Onco Targets Ther
Glavni autori: Gu, Xiaobin, Gao, Xian-Shu, Xiong, Wei, Guo, Wei, Han, Linjun, Bai, Yun, Peng, Chuan, Cui, Ming, Xie, Mu
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976917/
https://ncbi.nlm.nih.gov/pubmed/27536144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S110713
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items